How many employees work at Visus Therapeutics?
Visus Therapeutics, Inc. has approximately 9 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Visus Therapeutics’s total headcount has declined 50.0% from 18 employees in 2023 to 9 in 2026.
Is Visus Therapeutics hiring right now?
No, Visus Therapeutics is not actively hiring. Visus Therapeutics had 0 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About Visus Therapeutics’s Workforce
Visus Therapeutics, Inc. is a Pharmaceuticals company that employs 9 people worldwide as of March 2026. It is the 9th-largest by headcount among its peers. Founded in 2019, the company is headquartered in Seattle, Washington.
Visus Therapeutics's workforce has declined 50.0% from 2023 to 2026, though it is up 19.6% year over year in 2026. It fell to a low of 1 in 2024 Q4 before recovering. Its workforce is concentrated most in North America (86.3%), followed by Western Europe (13.7%).
Visus Therapeutics's functional groups are Engineering (47.8%), Sales and Marketing (26.1%), and Finance and Operations (26.0%), with Finance and Operations growing fastest (up 100.0%). The average salary is $153,634, highest in North America at a median of $138,000, up 24.2% year over year in 2026.
Visus Therapeutics's hiring activity held steady in 2026.
Sourced from Revelio Labs workforce data.
- Headquarters
- Seattle, Washington
- Founded
- 2019
- Industry
- Pharmaceuticals
- Employees
- 9
- YoY
- +19.6% (+7)
As of March 2026
Visus Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Visus Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsVisus Therapeutics Annual Employee Count (2023-2026)
- Visus Therapeutics had 9 employees in 2026, a 19.6% increase (+7) from 2025.
- Visus Therapeutics had 4 employees in 2025, a 58.2% increase (+3) from 2024.
- Visus Therapeutics had 1 employees in 2024, a 10.4% decline (-17) from 2023.
- Visus Therapeutics had 18 employees in 2023, a 0% no change (-1) from 2022.
Visus Therapeutics's total workforce has grown from 1 employees in 2024 to 9 in 2026. Visus Therapeutics's headcount peaked at 18 in 2023 before declining in 2024 and recovering through 2025 and 2026.
Visus Therapeutics, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 9 | +7 | +19.6% |
| 2025 | Q4 | 4 | +3 | +58.2% |
| 2025 | Q3 | 4 | -12 | +14.0% |
| 2025 | Q2 | 2 | -14 | +0.0% |
| 2025 | Q1 | 2 | -15 | -10.3% |
| 2024 | Q4 | 1 | -17 | -10.4% |
| 2024 | Q3 | 16 | -2 | -5.8% |
| 2024 | Q2 | 16 | -2 | -5.8% |
| 2024 | Q1 | 17 | -2 | +0.0% |
| 2023 | Q4 | 18 | -1 | +0.0% |
| 2023 | Q3 | 18 | -1 | +0.0% |
| 2023 | Q2 | 18 | -2 | +0.0% |
See Visus Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataVisus Therapeutics Employee Count by Region (2026)
North America accounts for the largest share of Visus Therapeutics's global workforce with approximately 86% of total employees, followed by Western Europe.
Visus Therapeutics employees by region
| Region | Employees | % of Total |
|---|---|---|
| North America | 8 | 86.3% |
| Western Europe | 1 | 13.7% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataVisus Therapeutics Employee Count by Department (2026)
Visus Therapeutics's employee groups are Engineering (47.8%), Sales and Marketing (26.1%), and Finance and Operations (26.0%).
Visus Therapeutics employees by department
| Department | Employees | % of Total |
|---|---|---|
| Engineering | 4 | 47.8% |
| Sales and Marketing | 2 | 26.1% |
| Finance and Operations | 2 | 26.0% |
Compare Visus Therapeutics's department mix to industry peers.
See Full DataVisus Therapeutics Employee Salary by Region (2026)
Visus Therapeutics's average employee salary is $153,634 globally. Employees in North America receive the highest compensation.
Visus Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $138,000 |
Unlock salary by role, level, and city — and compare to Visus Therapeutics's industry peers.
Unlock Salary DataVisus Therapeutics Job Openings and Hiring Trends (2023-2026)
- Visus Therapeutics had 0 active job postings in 2026, a 0% no change from 2025.
- Visus Therapeutics had 0 active job postings in 2025, a 200.0% decline (-2) from 2024.
- Visus Therapeutics had 2 active job postings in 2024, a 200.0% increase (+2) from 2023.
- Visus Therapeutics had 0 active job postings in 2023, a 200.0% decline from 2022.
- Hiring velocity in 2026: 0 new roles/month, up from 0 in 2025 and 0 in 2024.
Visus Therapeutics's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Visus Therapeutics
- How fast is Visus Therapeutics growing?
- In 2026, Visus Therapeutics's headcount grew 19.6% to 9 employees, up from 2 in 2025.
- See the full headcount history
- Where are Visus Therapeutics employees located?
- Most Visus Therapeutics employees are based in North America (86.3% of headcount), followed by Western Europe.
- Explore where the workforce is based
- What is the average salary at Visus Therapeutics?
- The average employee salary at Visus Therapeutics is approximately $153.6k per year.
- Analyze the salary distribution
- How many new job postings does Visus Therapeutics open per year?
- In Q1 2026, Visus Therapeutics opened 0 new job postings. In 2025, Visus Therapeutics opened 0 new job postings — about 0 per month.
- Track hiring trends by role
- When was Visus Therapeutics founded and where is it headquartered?
- Visus Therapeutics was founded in 2019 and is headquartered in Seattle, Washington.
- Compare Visus Therapeutics to industry peers
Speak with a workforce expert about Visus Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.